Purple Biotech Ltd.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Purple Biotech is an Israeli biopharmaceutical company focused on developing innovative cancer therapies and advancing oncology research.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-23 16:18 |
Foreign Filer Report
6K: Purple Biotech Announces Highlights Significant Advantages of the Novel CAP…
|
English | 191.8 KB | |
| 2025-06-23 16:18 |
Regulatory News Service
6K: Purple Biotech Announces Highlights Significant Advantages of the Novel CAP…
|
English | 36.9 KB | |
| 2025-06-17 17:08 |
Foreign Filer Report
6K: Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients w…
|
English | 214.2 KB | |
| 2025-06-17 17:08 |
Regulatory News Service
6K: Purple Biotech Announces Initiation of Phase 2 Study of NT219 in Patients w…
|
English | 36.8 KB | |
| 2025-06-04 16:12 |
Regulatory News Service
Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Pla…
|
English | 156.4 KB | |
| 2025-06-04 16:12 |
Regulatory News Service
Poster Presentation at EACR 2025 on its Novel CAPTN-3 Tri-Specific Antibody Pla…
|
English | 36.6 KB | |
| 2025-05-21 16:22 |
Earnings Release
Purple Biotech Reports First Quarter 2025 Financial Results
|
English | 219.5 KB | |
| 2025-05-21 16:22 |
Quarterly Report
Purple Biotech Reports First Quarter 2025 Financial Results
|
English | 36.8 KB | |
| 2025-05-12 16:39 |
Foreign Filer Report
6K: Purple Biotech Appoints Shai Lankry as Chief Financial Officer
|
English | 175.6 KB | |
| 2025-05-12 16:39 |
Board/Management Change
6K: Purple Biotech Appoints Shai Lankry as Chief Financial Officer
|
English | 36.6 KB | |
| 2025-05-07 01:45 |
Company Presentation
6K: Purple Biotech Corporate Presentation May 2025
|
English | 30.7 MB | |
| 2025-05-07 01:45 |
Company Presentation
6K: Purple Biotech Corporate Presentation May 2025
|
English | 36.6 KB | |
| 2025-05-04 00:11 |
Foreign Filer Report
6K: Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic …
|
English | 205.5 KB | |
| 2025-05-04 00:11 |
Foreign Filer Report
6K: Purple Biotech Reports Final Data from Phase 2 Study of CM24 in Pancreatic …
|
English | 36.8 KB | |
| 2025-04-28 18:49 |
Foreign Filer Report
6K:Purple Biotech Reports Positive NT219 Data at AACR for Colorectal and Head a…
|
English | 200.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |